ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy

Stock Information for ARCA biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ARCA biopharma Inc.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WIRE, ABIO, SWAV, MODN
Kuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq - SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE - MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, MODN, ABIO
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq - SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE - MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.